Makaleler

Tümü (7)

SCI-E, SSCI, AHCI (5)

SCI-E, SSCI, AHCI, ESCI (6)

ESCI (1)

Scopus (6)

TRDizin (1)

2025

2025

1. Kas-İnvaziv mesane kanserinde neoadjuvan ve adjuvan kemoterapinin sağkalım üzerine etkinliği: Çok merkezli çalışma

majıdova n., Öztürk A. E., Çolak R., yalıcı ö., İÇLİ M. C., KÖKSAL B., et al.

Turkish Journal of Clinics and Laboratory , cilt.16, sa.1, ss.123-130, 2025 (TRDizin)

2024

2024

2. Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

On S., KÖKSAL B., ARIK Z., Caner B., ERCAN UZUNDAL D., YAZICI O., et al.

CURRENT ONCOLOGY , cilt.31, sa.11, ss.6803-6813, 2024 (SCI-Expanded, Scopus)

2024

2024

3. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

AKYILDIZ A., GÜVEN D. C., KÖKSAL B., KARAOĞLAN B. B., Kivrak D., Ismayilov R., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.281, sa.9, ss.4991-4999, 2024 (SCI-Expanded, Scopus)

2024

2024

4. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer

YILDIRIM H. Ç., Buyukkor M., KAVGACI G., ŞAHİN ÇELİK B., BİR YÜCEL K., DURSUN B., et al.

MEDICINE , cilt.103, sa.30, 2024 (SCI-Expanded, Scopus)

2024

2024

5. Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report

KAVGACI G., KÖKSAL B., ARIK Z., BARIŞTA İ., AKIN S.

PLASMATOLOGY , cilt.18, 2024 (ESCI, Scopus)

2024

2024

6. The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study

KUŞ F., GÜVEN D. C., YILDIRIM H. Ç., Akagunduz B., Karakaya S., SÜTCÜOĞLU O., et al.

INTEGRATIVE CANCER THERAPIES , cilt.23, 2024 (SCI-Expanded, Scopus)

2024

2024

7. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

YILDIRIM H. Ç., Kapar C., KÖKSAL B., Seyyar M., Sanci P. C., Guliyev M., et al.

Journal of Chemotherapy , 2024 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2024

2024

1. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

Akyildiz A., Guven D. C., Koksal B., Karaoglan B. B., Salim D. K., Sutcuoglu O., et al.

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)